CZ2003822A3 - Farmaceutická kompozice pro topické dodávání inhibitorů enzymu cyklooxygenázy-2 - Google Patents

Farmaceutická kompozice pro topické dodávání inhibitorů enzymu cyklooxygenázy-2 Download PDF

Info

Publication number
CZ2003822A3
CZ2003822A3 CZ2003822A CZ2003822A CZ2003822A3 CZ 2003822 A3 CZ2003822 A3 CZ 2003822A3 CZ 2003822 A CZ2003822 A CZ 2003822A CZ 2003822 A CZ2003822 A CZ 2003822A CZ 2003822 A3 CZ2003822 A3 CZ 2003822A3
Authority
CZ
Czechia
Prior art keywords
composition
mixtures
group
glycol
sorbitan
Prior art date
Application number
CZ2003822A
Other languages
Czech (cs)
English (en)
Inventor
Vinod Kumar Arora
Ajay Kumar Singla
Mukesh Kumar
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of CZ2003822A3 publication Critical patent/CZ2003822A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CZ2003822A 2000-08-29 2001-08-28 Farmaceutická kompozice pro topické dodávání inhibitorů enzymu cyklooxygenázy-2 CZ2003822A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN779DE2000 IN191090B (enExample) 2000-08-29 2000-08-29

Publications (1)

Publication Number Publication Date
CZ2003822A3 true CZ2003822A3 (cs) 2003-08-13

Family

ID=11097085

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2003822A CZ2003822A3 (cs) 2000-08-29 2001-08-28 Farmaceutická kompozice pro topické dodávání inhibitorů enzymu cyklooxygenázy-2

Country Status (13)

Country Link
US (1) US20040029946A1 (enExample)
EP (1) EP1315500A4 (enExample)
JP (1) JP2004525859A (enExample)
CN (1) CN1227012C (enExample)
AU (1) AU2001284321A1 (enExample)
BR (1) BR0113661A (enExample)
CA (1) CA2420804A1 (enExample)
CZ (1) CZ2003822A3 (enExample)
IN (1) IN191090B (enExample)
RU (1) RU2003108335A (enExample)
SK (1) SK3622003A3 (enExample)
WO (1) WO2002017923A1 (enExample)
ZA (1) ZA200301680B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2002096435A2 (en) * 2001-05-31 2002-12-05 Pharmacia Corporation Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US6830744B2 (en) * 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
IL165383A0 (en) * 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
AU2003238543B2 (en) * 2002-06-25 2008-02-28 Acrux Dds Pty Ltd Transdermal aerosol compositions
AUPS317102A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Transdermal aerosol compositions
WO2004000263A1 (en) 2002-06-25 2003-12-31 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
JP4283507B2 (ja) * 2002-08-02 2009-06-24 久光製薬株式会社 経皮投与用貼付剤
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
AU2003265624B2 (en) * 2003-08-21 2011-03-31 Abeona Therapeutics Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
EP1682060A1 (en) * 2003-10-14 2006-07-26 Dermatrends, Inc. Enhancing transdermal administration of hydrophilic drugs
US20070196301A1 (en) 2005-12-21 2007-08-23 L'oreal Cosmetic composition with a volumizing effect
FR2894811B1 (fr) † 2005-12-21 2008-02-22 Oreal Composition cosmetique a effet volumateur
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
MX2007009796A (es) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
WO2009076302A1 (en) * 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
CA2823534C (en) * 2010-12-28 2018-09-11 Mary Kay Inc. Topical composition comprising a psidium guajava extract and a kunzea ericoides extract for providing sebum control and treating acne
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) * 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
JP6495723B2 (ja) * 2015-04-14 2019-04-03 帝國製薬株式会社 セレコキシブの経皮吸収製剤
CN105663032A (zh) * 2016-02-23 2016-06-15 青岛科技大学 一种维他昔布软膏剂的制备方法
IL298681A (en) 2016-08-02 2023-01-01 Univ Virginia Commonwealth Preparations
CN107158407A (zh) * 2017-06-17 2017-09-15 安徽仁之堂药业有限公司 一种中药提取所得挥发油的制剂助剂
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
MX368750B (es) 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
CA3164165A1 (en) * 2020-01-10 2021-07-15 Robert Bruce Register Topical compositions containing rofecoxib and methods of making and using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
JP3267300B2 (ja) * 1995-02-13 2002-03-18 ジー．ディー．サール アンド カンパニー 炎症の治療のための置換イソオキサゾール
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
EP0863134A1 (en) * 1997-03-07 1998-09-09 Merck Frosst Canada Inc. 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
US5998487A (en) * 1998-04-08 1999-12-07 Colgate-Palmolive Company Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
WO2000072883A2 (en) * 1999-06-02 2000-12-07 Aviana Biopharm Pharmaceutical transdermal compositions
IN191512B (enExample) * 2000-01-21 2003-12-06 Panacea Biotech

Also Published As

Publication number Publication date
CN1469748A (zh) 2004-01-21
BR0113661A (pt) 2004-07-06
EP1315500A4 (en) 2006-05-31
JP2004525859A (ja) 2004-08-26
WO2002017923A1 (en) 2002-03-07
IN191090B (enExample) 2003-09-20
RU2003108335A (ru) 2004-09-10
EP1315500A1 (en) 2003-06-04
ZA200301680B (en) 2004-06-23
CN1227012C (zh) 2005-11-16
CA2420804A1 (en) 2002-03-07
AU2001284321A1 (en) 2002-03-13
SK3622003A3 (en) 2003-09-11
US20040029946A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
CN1227012C (zh) 用于局部传送环加氧酶－2酶抑制剂的药物组合物
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
US10117829B2 (en) Diclofenac formulations
US20120259018A1 (en) Composition of dexibuprofen transdermal hydrogel
US20120157536A1 (en) Composition for transdermal administration of non-steroidal anti-flammatory drug
FR2814074A1 (fr) Nouvelles compositions estro-progestatives topiques a effet systemique
JP2011046737A (ja) 加温性で無刺激性の潤滑剤抗真菌ゲル組成物
RU2306133C2 (ru) Согревающие и нераздражающие смазывающие противогрибковые гелеобразные композиции
CN104797252A (zh) 减轻噪音厌恶的兽医方法
US20050049291A1 (en) Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors
CN1668334A (zh) 经皮吸收制剂
JP4195178B2 (ja) 消炎鎮痛外用剤
JP2008519012A (ja) デトミジンを含む経粘膜動物用組成物
EP3284484A1 (en) Transdermal preparation containing antifungal active material
KR101894891B1 (ko) 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형
WO2006103638A2 (en) Topical pharmaceutical compositions of terbinafine and processes for their preparation
US11376213B2 (en) Topical pharmaceutical formulation
JPH11343248A (ja) 局所タ―ゲティング用組成物
TW200404001A (en) Prostaglandin compositions and methods of treatment for male erectile dysfunction